CERS
Cerus Corp Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$2.28Close
$438.1MMarket cap
$1.40 – $3.2852-week range
Nov 2, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 3 of 8 trend conditions
- Far from its high 30% below its 52-week high
- Results soon Nov 2, 2026, in 1 day
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
30%
1wk
down 2.1%
price change
1mo
down 4.2%
price change
12-month return
up 63%
market up 11% ·
its own up 46%
F-score
—
— Not assessed
Altman Z
-3.82
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
6.8×
price / book
Earnings yield
down 1.7%
EBIT / enterprise value
Cheaper than
23%
of the market · expensive
Revenue growth
up 16%
year on year
EPS growth
—
latest quarter
Sales growth
up 10%
latest quarter · -15 pts
ROE
down 26%
return on equity
Free cash margin
0%
$1.1M FCF
D/E
1.31
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Trade setup
ATR%
4.4%
$0.10 a day · 2×ATR $2.08
RS
63 / 99
vs the universe
Trend
3 / 8
trend template
Relative volume
0.9×
vs 50-day average
Up/down volume
1.05
50 sessions
Implied move
—
no option chain · report Nov 2, 2026
Trend template · 3 of 8
- Price above the 150 and 200-day averages: fails
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: fails
- Price above the 50-day average: fails
- At least 30% above the 52-week low: passes
- Within 25% of the 52-week high: fails
- RS rank 70 or higher: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Shareholders diluted The share count rose 3.4% over the year, from 186m to 192m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Jul 30, 2026
Last shock
Jul 31, 2026-26% in one session3.1× volumeon results+6% since
Financials
- Net -7%
- Free cash 0%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $114.2M | $159.5M | $188.3M | $186.8M | $201.3M | $233.8M |
| Gross margin | 64% | — | — | — | — | — |
| Operating income | -$58.3M | -$48.9M | -$34.1M | -$30.1M | -$14.2M | -$8.7M |
| Net income | -$59.9M | -$54.4M | -$42.8M | -$37.5M | -$20.9M | -$15.6M |
| Net margin | -52% | -34% | -23% | -20% | -10% | -7% |
| Earnings per share | -$0.37 | -$0.32 | -$0.24 | -$0.21 | -$0.11 | -$0.08 |
| Free cash flow | -$43.4M | -$34.8M | -$27.6M | -$47.8M | $8.5M | $1.1M |
| Free cash margin | -38% | -22% | -15% | -26% | 4% | 0% |
| Cash | $36.6M | $48.8M | $35.6M | $11.6M | $20.3M | $20.0M |
| Long-term debt | — | — | $69.9M | $80.0M | $84.3M | $84.0M |
| Shareholders' equity | $103.8M | $84.6M | $67.6M | $52.6M | $56.1M | $64.2M |
| Shares outstanding | 168.17m | 173.67m | 177.58m | 181.25m | 185.77m | 192.14m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Jul 30, 2026 | Quarterly ↗ | Jun 30, 2026 | 30d |
| Apr 30, 2026 | Quarterly ↗ | Mar 31, 2026 | 30d |
| Mar 2, 2026 | Annual ↗ | Dec 31, 2025 | 61d |
| Nov 6, 2025 | Quarterly ↗ | Sep 30, 2025 | 37d |
| Aug 5, 2025 | Quarterly ↗ | Jun 30, 2025 | 36d |
| May 1, 2025 | Quarterly ↗ | Mar 31, 2025 | 31d |
| Feb 26, 2025 | Annual ↗ | Dec 31, 2024 | 57d |
| Oct 31, 2024 | Quarterly ↗ | Sep 30, 2024 | 31d |
| Aug 1, 2024 | Quarterly ↗ | Jun 30, 2024 | 32d |
| May 2, 2024 | Quarterly ↗ | Mar 31, 2024 | 32d |
| Mar 5, 2024 | Annual ↗ | Dec 31, 2023 | 65d |
| Nov 2, 2023 | Quarterly ↗ | Sep 30, 2023 | 33d |
Current reports
| Filed | Disclosed |
|---|---|
| Jul 30, 2026 | Results ↗ |
| Jul 10, 2026 | Director or officer change ↗ |
| Jun 8, 2026 | Material agreement · Agreement ended · New obligation ↗ |
| Jun 3, 2026 | Director or officer change · Shareholder vote ↗ |
| Apr 30, 2026 | Results ↗ |
| Apr 21, 2026 | Director or officer change ↗ |
| Mar 16, 2026 | Director or officer change ↗ |
| Mar 2, 2026 | Results ↗ |
| Jan 23, 2026 | Director or officer change ↗ |
| Jan 12, 2026 | Results ↗ |
| Nov 6, 2025 | Results ↗ |
| Aug 5, 2025 | Results ↗ |